Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin.

Mol Cancer · 2011 · PMC3083377 · PMID 21470426

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

There was a trend towards a worse outcome in both subgroups, but the difference did not achieve significance.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.